Invesco Ltd. - FIVE PRIME THERAPEUTICS INC ownership

FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 128 filers reported holding FIVE PRIME THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 0.69 and the average weighting 0.1%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of FIVE PRIME THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$30,616,000
+7.3%
812,737
-51.5%
0.01%0.0%
Q4 2020$28,532,000
+10707.6%
1,677,382
+2876.5%
0.01%
Q3 2020$264,000
-73.3%
56,354
-65.2%
0.00%
Q2 2020$987,000
+585.4%
161,855
+155.2%
0.00%
Q1 2020$144,000
+9.9%
63,413
+122.8%
0.00%
Q4 2019$131,000
+11.0%
28,467
-6.3%
0.00%
Q3 2019$118,000
-37.9%
30,392
-3.7%
0.00%
Q2 2019$190,000
-68.5%
31,560
-30.0%
0.00%
Q1 2019$604,000
+49.1%
45,074
+3.4%
0.00%
Q4 2018$405,000
-23.1%
43,581
+15.1%
0.00%
Q3 2018$527,000
-11.9%
37,872
+0.1%
0.00%
Q2 2018$598,000
+28.6%
37,842
+39.7%
0.00%
Q1 2018$465,000
+40.1%
27,083
+78.6%
0.00%
Q4 2017$332,000
-44.0%
15,164
+4.6%
0.00%
Q3 2017$593,000
+37.9%
14,498
+1.6%
0.00%
Q2 2017$430,000
-73.4%
14,272
-68.1%
0.00%
-100.0%
Q1 2017$1,617,000
-84.4%
44,749
-78.4%
0.00%
-66.7%
Q4 2016$10,368,000
+13.2%
206,901
+18.6%
0.00%0.0%
Q3 2016$9,158,000
+28.1%
174,488
+0.9%
0.00%0.0%
Q2 2016$7,150,000
+137.9%
172,911
+133.7%
0.00%
+200.0%
Q1 2016$3,006,000
+60020.0%
73,978
+33991.2%
0.00%
Q2 2015$5,000
-99.6%
217
-99.5%
0.00%
Q4 2014$1,125,00041,6830.00%
Other shareholders
FIVE PRIME THERAPEUTICS INC shareholders Q3 2017
NameSharesValueWeighting ↓
Versant Venture Management, LLC 1,092,152$16,808,219,0009.64%
GREAT POINT PARTNERS LLC 1,226,785$18,880,0007.47%
Ghost Tree Capital, LLC 500,000$7,695,0003.46%
RTW INVESTMENTS, LP 713,954$10,988,0003.41%
ARMISTICE CAPITAL, LLC 506,000$7,787,0002.66%
EcoR1 Capital, LLC 149,000$2,293,0001.04%
Eventide Asset Management 1,164,900$17,928,0001.04%
Telemetry Investments, L.L.C. 102,500$1,577,0000.68%
J. Goldman & Co LP 313,527$4,825,0000.41%
AWM Investment Company, Inc. 118,199$1,819,0000.35%
View complete list of FIVE PRIME THERAPEUTICS INC shareholders